Taking advantage of the radiation properties of 99m Tc and 186/188 Re and the photophysical characteristics of the {M(CO) 3 } + moiety (M = Re), we developed a multifunctional silica platform with the theranostic pair 99m Tc/Re with high potential for (nano)medical applications. Starting with a general screening to evaluate the most suitable mesoporous silica construct and the development of appropriate chelate systems, multifunctional mesoporous silica microparticles (SBA-15) were synthesized. These particles act as a model towards the synthesis of the corresponding nanoconstructs. The particles can be modified at the external surface with a targeting function and labeled with the {M(CO) 3 } + moiety (M = 99m Tc, Re) at the pore surface. Thus, a silica platform is realized, whose bioprofile is not altered by the loaded modalities. The described synthetic procedures can be applied to establish a target-specific theranostic nanoplatform, which enables the combination of fluorescence and radio imaging, with the possibility of radio-and chemotherapy.
Introduction
For many decades, the nuclear isomer technetium-99m ( 99m Tc, t 1/2 = 6 h, E γ = 141 keV) has been the most frequently used radio metal for applications in nuclear medical diagnostics [1] [2] [3] [4] [5] . In combination with isotopes 186 and 188 of its heavier homolog rhenium ( 186/188 Re), it represents one of the first "theranostic pairs" for nuclear medical diagnosis and therapy [6] . Recently, a conceptual extension of the "theranostic pair" Tc/Re was described by the combination of a 99m Tc-based bio-mimetic with its organometallic but non-radioactive rhenium homologue [7] . The rhenium complex should be therapeutically active through its structure, while the 99m Tc homologue allows for visualizing the pharmacology. Besides the use of Tc and Re as a "theranostic pair", Stephenson et al. demonstrated that the two homologues allow the development of multimodal imaging probes [8] . A fluorescent Re-complex and the analogous 99m Tc-complex provide the direct combination of optical imaging with high spatial resolution (in vitro) and radioimaging with sensitive detection of biological processes deep in the body (in vivo). By combining the multimodality of the {M(CO) 3 } + moiety (M = 99m Tc, Re) with the theranostic properties of the 99m Tc/ 186/188 Re pair, a multifunctional system is realized, which can be applied for diagnosis (radio and UV imaging) and (radio) therapy. This represents a new strategy for the application of Tc and Re in medicine and will enable new opportunities for these two elements. To apply multimodality probes in medicine, they have to be target-specific. To design a target-specific molecular Currently, multifunctional nanoplatforms are a focus in nanomedicine [9] . Nanoparticles are ideal for combining different modalities and exhibit several advantages as compared to traditional diagnostic and therapeutic methods. They can easily integrate more than one kind of imaging or therapeutic agent. Large amounts of imaging agents or drugs can be introduced through chemical conjugation or simple loading due to the large surface area or interior cargo volume of the nanoparticles. Moreover, nanoparticles can target disease sites for drug delivery and imaging through physicochemical optimization of size and surface properties, and especially through the attachment of specific targeting moieties. Alteration of physicochemical properties can also be used to optimize the circulation time in the blood [10] . A further interesting feature of nanoparticles in radiopharmacy is the possibility to accumulate more than one radioactive moiety per target receptor. This leads to higher activity at the target site (amplification effect) as compared to directly labeled targeting molecules, which can only deliver one radioactive moiety per target receptor [11] . These beneficial properties of nanoparticles lead to a better contrast of the diagnostic image. The overall radioactivity can be reduced, leading to lower dose rates for the patients. In the past, different nanomaterials have been labeled with 99m Tc in a nonspecific fashion, such as magnetic nanoparticles [12] [13] [14] [15] , organo-germanium compounds [16] , carbon nanotubes [17] , fullerene derivatives [18] , polymers [19] , pullulan acetates [20] , chitosans [21, 22] , and tripalmitins [23] . In all these approaches, [ 99m TcO4] − activity has been reduced in the presence of the nanoparticles. This leads to a random distribution of 99m Tc at the surface of the nanoparticles and an undefined binding mode at the particle surface. This unspecific labeling method is fast, but unambiguous characterization of the labeled nanoparticles is challenging. For the preparation of well-defined mesoporous nanoparticles, whose external and pore surface can be addressed independently at different stages of the synthesis, a specific and reproducible method to bind technetium and rhenium is required. Furthermore, developing a well-defined labeling procedure for nanoparticles with 99m Tc can serve as a useful tool to investigate general aspects of nanoparticles, such as entry routes, pharmacokinetics, and the molecular mechanism of nanoparticle toxicity [24] .
Mesoporous silica particles show highly interesting properties that make them promising candidates for target-specific, multifunctional nanoplatforms ( Figure 1 ). Especially, selective functionalization of the external and the pore surface area as well as cargo loading are established features for this type of material [25] [26] [27] [28] [29] . Besides applications in catalysis [30] [31] [32] [33] [34] [35] and sensing [36] , MCM-41 (Mobil Composition of Matter No. 41), a prominent representative of mesoporous silica Currently, multifunctional nanoplatforms are a focus in nanomedicine [9] . Nanoparticles are ideal for combining different modalities and exhibit several advantages as compared to traditional diagnostic and therapeutic methods. They can easily integrate more than one kind of imaging or therapeutic agent. Large amounts of imaging agents or drugs can be introduced through chemical conjugation or simple loading due to the large surface area or interior cargo volume of the nanoparticles. Moreover, nanoparticles can target disease sites for drug delivery and imaging through physicochemical optimization of size and surface properties, and especially through the attachment of specific targeting moieties. Alteration of physicochemical properties can also be used to optimize the circulation time in the blood [10] . A further interesting feature of nanoparticles in radiopharmacy is the possibility to accumulate more than one radioactive moiety per target receptor. This leads to higher activity at the target site (amplification effect) as compared to directly labeled targeting molecules, which can only deliver one radioactive moiety per target receptor [11] . These beneficial properties of nanoparticles lead to a better contrast of the diagnostic image. The overall radioactivity can be reduced, leading to lower dose rates for the patients. In the past, different nanomaterials have been labeled with 99m Tc in a nonspecific fashion, such as magnetic nanoparticles [12] [13] [14] [15] , organo-germanium compounds [16] , carbon nanotubes [17] , fullerene derivatives [18] , polymers [19] , pullulan acetates [20] , chitosans [21, 22] , and tripalmitins [23] . In all these approaches, [ 99m TcO 4 ] − activity has been reduced in the presence of the nanoparticles. This leads to a random distribution of 99m Tc at the surface of the nanoparticles and an undefined binding mode at the particle surface. This unspecific labeling method is fast, but unambiguous characterization of the labeled nanoparticles is challenging. For the preparation of well-defined mesoporous nanoparticles, whose external and pore surface can be addressed independently at different stages of the synthesis, a specific and reproducible method to bind technetium and rhenium is required. Furthermore, developing a well-defined labeling procedure for nanoparticles with 99m Tc can serve as a useful tool to investigate general aspects of nanoparticles, such as entry routes, pharmacokinetics, and the molecular mechanism of nanoparticle toxicity [24] .
Mesoporous silica particles show highly interesting properties that make them promising candidates for target-specific, multifunctional nanoplatforms ( Figure 1 ). Especially, selective functionalization of the external and the pore surface area as well as cargo loading are established features for this type of material [25] [26] [27] [28] [29] . Besides applications in catalysis [30] [31] [32] [33] [34] [35] and sensing [36] , MCM-41 (Mobil Composition of Matter No. 41), a prominent representative of mesoporous silica particles, was first proposed as a drug delivery system in 2001 [37] . Since then, extensive research efforts have been dedicated to this subject, leading to sophisticated systems for drug delivery and controlled drug release [38] [39] [40] [41] [42] [43] . Therefore, mesoporous silica particles enable the development of carrier systems, which combine targeting moieties, Tc-and Re-based imaging functions (radio-or UV-labels), and drug loading in a well-defined way. This creates multifunctional nanoplatforms, which are extremely suited for future applications in the evolving field of nanomedicine and personalized medicine [44] .
Herein, we describe the development of a Tc and Re based multifunctional silica microplatform. This platform acts as a model towards the synthesis of the corresponding nanoconstructs. Starting with a general screening of different mesoporous silica microparticles to evaluate the most suitable construct and the development of appropriate chelate systems, multifunctional mesoporous silica particles, such as SBA-15 (Santa Barbara Amorphous type material No. 15) and spherical SBA-15 (sSBA-15), are synthesized. These particles can be labeled with the {M(CO) 3 } + moiety (M = 99m Tc, Re) at the pore surface.
Results and Discussion

Evaluation of Mesoporous Silica Particles
The term mesoporous silica represents a large family of compounds with a plethora of properties. To understand which type of mesoporous silica particle is suitable as a theranostic platform, in a first step a variety of different types of mesoporous silica microparticles, such as MCM-41 (Mobil Composition of Matter No. 41) [45] , ASNCs (arrays of silica nanochannels) [46] , and SBA-15 (Santa Barbara Amorphous type material No. 15) [47] were evaluated (for details see Supplementary Materials). All studied materials are established mesoporous silica microparticles. The screening was done by comparing the labeling performance of the functionalized silica microparticles, applying a new 99m Tc labeling strategy [48, 49] . The (3 + 2)-cycloaddition reaction of the [ 99m TcO 3 (tacn)] + complex (tacn = 1,3,5-triazacacyclononane) with surface-grafted norbornene proceeds stereoselectively and with high reaction rates [50] . Therefore, it is an excellent method for fast and efficient screening of different materials. For this screening, 5-(bicycloheptenyl)triethoxysilane (NorboSi) was grafted to the surfaces of the silica particles under study in the first step. In the second step, [ 99m TcO 3 (tacn)] + was reacted with these modified particles. Progress of labeling can be monitored by the decrease of the activity in the solution over time. Furthermore, the labeled particles were decomposed in 1M NaOH as control and the released activity was correlated to the observed decrease of activity in the solution by radio-HPLC. Figure 2 shows the labeling progress for two representative examples of the studied microparticles (MCM-41 and SBA-15).
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Results and Discussion
Evaluation of Mesoporous Silica Particles
The term mesoporous silica represents a large family of compounds with a plethora of properties. To understand which type of mesoporous silica particle is suitable as a theranostic platform, in a first step a variety of different types of mesoporous silica microparticles, such as MCM-41 (Mobil Composition of Matter No. 41) [45] , ASNCs (arrays of silica nanochannels) [46] , and SBA-15 (Santa Barbara Amorphous type material No. 15) [47] were evaluated (for details see Supplementary Materials ). All studied materials are established mesoporous silica microparticles. The screening was done by comparing the labeling performance of the functionalized silica microparticles, applying a new 99m Tc labeling strategy [48, 49] . The (3 + 2)-cycloaddition reaction of the [ 99m TcO3(tacn)] + complex (tacn = 1,3,5-triazacacyclononane) with surface-grafted norbornene proceeds stereoselectively and with high reaction rates [50] . Therefore, it is an excellent method for fast and efficient screening of different materials. For this screening, 5-(bicycloheptenyl)triethoxysilane (NorboSi) was grafted to the surfaces of the silica particles under study in the first step. In the second step, [ 99m TcO3(tacn)] + was reacted with these modified particles. Progress of labeling can be monitored by the decrease of the activity in the solution over time. Furthermore, the labeled particles were decomposed in 1M NaOH as control and the released activity was correlated to the observed decrease of activity in the solution by radio-HPLC. Figure 2 shows the labeling progress for two representative examples of the studied microparticles (MCM-41 and SBA-15). The screening disclosed a remarkable difference in the labeling performance of the modified silica particles depending on the porosity. Whereas SBA-15 particles showed very fast and almost complete labeling (more than 90% labeling yield in less than 1 min reaction time), the MCM-41 particles had a much slower labeling rate. After 2 h reaction time, a labeling yield of only 60% was observed. Analysis of the gained data of all studied materials shows that silica particles with more accessible surface area lead to higher rates for the 99m Tc-labeling. For mesoporous silica microparticles, most of the surface area (roughly 90%) is located in the pores. A larger pore diameter gives enhanced access for [ 99m TcO 3 (tacn)] + to the norbornene decorated pores. As a consequence, particles with larger average pore size, such as SBA-15 (7-7.5 nm), show superior labeling performance as compared to particles with significantly smaller average pore size, such as MCM-41 (4 nm). The amount of grafted norbornenesilane (as determined by elemental analysis) has no significant influence as compared to the much more crucial pore size and accessible surface area. Due to the outstanding labeling performance of SBA-15 microparticles in contrast to all other tested silica particles, only this class of particles was considered for further investigation. In contrast to the synthetic procedure for SBA-15 microparticles, no synthetic procedures for well-defined SBA-15 nanoparticles are established. However, we expect that the herein reported procedures for the synthesis of bifunctionalized SBA-15 microparticles can be applied without further modifications for the synthesis of a SBA-15-based theranostic nanoplatform.
Synthesis of Chelators for Surface Modifications
By applying the (3 + 2)-cycloaddition [ 99m TcO 3 (tacn)] + with alkenes, an efficient new method was established to study the accessibility of functional groups (NorboSi) at silica particle surfaces. However, the high-valent chemistry of the { 99m TcO 3 } + was not established for theranostic applications due to the different redox potentials of the elements Tc and Re at their highest oxidation states [48] . This would limit a potential target-specific NorboSi@SBA-15 construct to radioimaging with 99m Tc and conventional drug loading, disregarding the full potential of the theranostic pair 99m Tc/Re. Therefore, an alternative approach with the {M(CO) 3 } + core (M = Re, 99m Tc) and SBA-15 particles was selected. For the development of theranostic nanoplatforms for (nuclear) medical applications, the bisquinoline/{M(CO) 3 } + (M = Re, 99m Tc) system is very well suited. The correlation of radioimaging and fluorescence studies with this system in single amino acid chelates was reported by Stephenson et al. [8] . SBA-15 particles carrying tridentate bisquinoline ligands enable the coordination of { 99m Tc(CO) 3 } + for radioimaging, { 185/187 Re(CO) 3 } + for optical imaging, and { 186/188 Re(CO) 3 } + for radiotherapy. Aiming at the synthesis of SBA-15 particles carrying bisquinoline chelates, a successive synthesis of the bisquinoline moiety (first by grafting of aminoalkyltriethoxysilane, followed by reductive amination with 2-quinolinecarboxaldehyde) at the SBA-15 surface is attractive. However, previous studies have shown that for this particular chelate, such a synthetic procedure does not lead to well-defined particles but generates a mixture of bi-and tridentate chelates at the silica surface [51] . Therefore, functionalization of SBA-15 by grafting of bisquinoline trialkoxysilanes is preferred. Different bisquinoline moieties with appropriate terminal substituents for the attachment of trialkoxysilanes have been synthesized (Scheme 1) in direct reductive amination. All compounds were isolated and characterized (see Supplementary Materials). The carboxyl group was introduced into the bisquinoline moiety by a one-step reaction with 4-aminobutyric acid (1d) or in a two-step procedure via deprotection of 1b (Scheme 2). Figure 3 ). The chloride anion obviously originated from the solvent. In the structure of [1c-3H]Cl(TFA)·(HTFA), two trifluoroacetic acid (TFA) anions share one proton. The two quinoline nitrogen atoms are protonated and both form hydrogen bonds with a common chloride anion (3.2019 (14) Å). In this structure, a TFA molecule is protonated, while the aliphatic tertiary amine is not (for crystallographic details see Supplementary Materials). This finding is in contrast with the expected pKa values of TFA and amines in solution. This rare structural motif of doubly-protonated pyridine rings pointing to a common hydrogen acceptor despite the presence of the more basic aliphatic nitrogen of the bispicolylamine has been described before [52, 53] . Scheme 1. Synthesis of different bisquinoline moieties with appropriate terminal substituents for the attachment of trialkoxysilanes. Reaction time was 2-25 h at room temperature. Note: STAB = sodium triacetoxyborohydride; DCE = 1,2-dichloroethane.
All compounds were isolated and characterized (see Supplementary Materials). The carboxyl group was introduced into the bisquinoline moiety by a one-step reaction with 4-aminobutyric acid (1d) or in a two-step procedure via deprotection of 1b (Scheme 2). All compounds were isolated and characterized (see Supplementary Materials). The carboxyl group was introduced into the bisquinoline moiety by a one-step reaction with 4-aminobutyric acid (1d) or in a two-step procedure via deprotection of 1b (Scheme 2). Figure 3 ). The chloride anion obviously originated from the solvent. In the structure of [1c-3H]Cl(TFA)·(HTFA), two trifluoroacetic acid (TFA) anions share one proton. The two quinoline nitrogen atoms are protonated and both form hydrogen bonds with a common chloride anion (3.2019 (14) Å). In this structure, a TFA molecule is protonated, while the aliphatic tertiary amine is not (for crystallographic details see Supplementary Materials). This finding is in contrast with the expected pKa values of TFA and amines in solution. This rare structural motif of doubly-protonated pyridine rings pointing to a common hydrogen acceptor despite the presence of the more basic aliphatic nitrogen of the bispicolylamine has been described before [52, 53] . (Figure 3 ). The chloride anion obviously originated from the solvent. In the structure of [1c-3H]Cl(TFA)·(HTFA), two trifluoroacetic acid (TFA) anions share one proton. The two quinoline nitrogen atoms are protonated and both form hydrogen bonds with a common chloride anion (3.2019 (14) Å). In this structure, a TFA molecule is protonated, while the aliphatic tertiary amine is not (for crystallographic details see Supplementary Materials). This finding is in contrast with the expected pKa values of TFA and amines in solution. This rare structural motif of doubly-protonated pyridine rings pointing to a common hydrogen acceptor despite the presence of the more basic aliphatic nitrogen of the bispicolylamine has been described before [52, 53] . Positive electron density between the trifluoroacetate molecule and the chloride anion indicates that the TFA is protonated and forms a hydrogen bond with the chloride anion (O33-Cl1: 2.993 (4) Å). The distance of this hydrogen bond is typical for such carboxylic acid-chloride interactions [55] . The overall crystal packing and the local environment of two pyridinium units next to the amine and one chloride ion next to the TFA are all responsible for this rare structural feature.
The synthesized chelates can be coupled to trialkoxysilanes via hydrosilylation and crossmetathesis (1a), amide bond formation (1c, 1d), or substitution reactions (1e). The amide bond formation of 3-aminopropyltriethoxysilane (APTES) with the acid bisquinoline moiety 1d is the most efficient synthetic approach (Scheme 3). The amide bond formation of APTES with a carboxylic acid represents a general strategy for the synthesis of functionalized trialkoxysilanes. It is fast and work up procedures are efficient. Extraction with dichloromethane (DCM) is sufficient to obtain the product in high purity. Tetramethylurea, the only side product, does not interfere with the subsequent grafting onto silica particles. As an alternative, the direct reductive amination of 2-quinolinecarboxaldehyde with APTES is a direct and efficient synthetic pathway (Scheme 4). Positive electron density between the trifluoroacetate molecule and the chloride anion indicates that the TFA is protonated and forms a hydrogen bond with the chloride anion (O33-Cl1: 2.993 (4) Å). The distance of this hydrogen bond is typical for such carboxylic acid-chloride interactions [55] . The overall crystal packing and the local environment of two pyridinium units next to the amine and one chloride ion next to the TFA are all responsible for this rare structural feature.
The synthesized chelates can be coupled to trialkoxysilanes via hydrosilylation and cross-metathesis (1a), amide bond formation (1c, 1d), or substitution reactions (1e). The amide bond formation of 3-aminopropyltriethoxysilane (APTES) with the acid bisquinoline moiety 1d is the most efficient synthetic approach (Scheme 3). Positive electron density between the trifluoroacetate molecule and the chloride anion indicates that the TFA is protonated and forms a hydrogen bond with the chloride anion (O33-Cl1: 2.993 (4) Å). The distance of this hydrogen bond is typical for such carboxylic acid-chloride interactions [55] . The overall crystal packing and the local environment of two pyridinium units next to the amine and one chloride ion next to the TFA are all responsible for this rare structural feature.
The synthesized chelates can be coupled to trialkoxysilanes via hydrosilylation and crossmetathesis (1a), amide bond formation (1c, 1d), or substitution reactions (1e). The amide bond formation of 3-aminopropyltriethoxysilane (APTES) with the acid bisquinoline moiety 1d is the most efficient synthetic approach (Scheme 3). The amide bond formation of APTES with a carboxylic acid represents a general strategy for the synthesis of functionalized trialkoxysilanes. It is fast and work up procedures are efficient. Extraction with dichloromethane (DCM) is sufficient to obtain the product in high purity. Tetramethylurea, the only side product, does not interfere with the subsequent grafting onto silica particles. As an alternative, the direct reductive amination of 2-quinolinecarboxaldehyde with APTES is a direct and efficient synthetic pathway (Scheme 4). The amide bond formation of APTES with a carboxylic acid represents a general strategy for the synthesis of functionalized trialkoxysilanes. It is fast and work up procedures are efficient. Extraction with dichloromethane (DCM) is sufficient to obtain the product in high purity. Tetramethylurea, the only side product, does not interfere with the subsequent grafting onto silica particles. As an alternative, the direct reductive amination of 2-quinolinecarboxaldehyde with APTES is a direct and efficient synthetic pathway (Scheme 4).
The ethoxysilane groups tend to hydrolyze and subsequently cross-link. This undesired side reaction has been addressed with EtOH for quenching of the residual reducing agent and C-18 flash chromatography purification. The isolated bisquinolinepropyltriethoxysilane (3) is stable as a solid The ethoxysilane groups tend to hydrolyze and subsequently cross-link. This undesired side reaction has been addressed with EtOH for quenching of the residual reducing agent and C-18 flash chromatography purification. The isolated bisquinolinepropyltriethoxysilane (3) is stable as a solid under ambient conditions over a period of several months. To evaluate the optimal reaction condition for the bifunctionalization of SBA-15 particles, compound 3 was grafted in high (160 M) and low (4 M) concentrations onto SBA-15 particles in dry toluene (Scheme 4).
The intact porous network of the modified SBA-15 particles (3@SBA-15) and successful grafting to the external surface as well as to the pore surface was confirmed by determining the decrease of the pore volume, the average pore diameter, and the total specific surface area (Table 1) .
Scheme 4.
Synthesis of 3 by reductive amination of 2-quinolinecarboxaldehyde with 3aminopropyltriethoxysilane in the presence of sodium triacetoxyborohydride (3.5 h, room temperature). Subsequent grafting of 3 to SBA-15 particles (2 h sonication, 60 • C).
The intact porous network of the modified SBA-15 particles (3@SBA-15) and successful grafting to the external surface as well as to the pore surface was confirmed by determining the decrease of the pore volume, the average pore diameter, and the total specific surface area (Table 1 ). The integrity of the grafted 3 was shown by decomposing the particles in 1M NaOD in D 2 O and subsequent analysis of the solution by 1 H-NMR and HR-ESI MS (high resolution-electrospray ionization mass spectrometry); an analytical strategy that was recently developed by Farinha and coworkers [56] . HR-ESI and 1 H-NMR allowed for unambiguous characterization of the hydrolyzed form of 3 and showed the release of EtOD due to the hydrolysis of Si-OEt groups not involved in the binding to SBA-15. Quantification of the 3@SBA-15 particles with high 3 content by elemental analysis showed 0.37 mmol of 3 per g of SBA-15, which correlates to 0.33 molecules of 3 per nm 2 surface of SBA-15. For comparison, applying 3 in lower concentrations for the synthesis led to 3@SBA-15 particles containing 0.08 mmol 3 per g particles.
Since 3 is highly stable, an alternative method for the synthesis of 3@SBA-15 is the co-condensation approach. This led to microparticles showing high loading and homogeneous distribution of the functionality over the complete porous network. Detailed synthetic procedures for all syntheses are described in the supplementary. (Figure 4) . Furthermore, the photophysical properties of 3-Re were studied. The UV-Vis spectrum of 3-Re shows a maximum absorbance at 323 nm with an extinction coefficient of 13696 M −1 ·cm −1 in CHCl 3 under ambient conditions. The emission spectrum shows two distinct emissions at 426 and 546 nm. These data are in good agreement with Stephenson et al [8] . Under an inert gas atmosphere (N 2 ), two emission maxima at 383 and 566 nm can be observed. The lifetime of the excited state determined in CHCl 3 /N 2 is 12.5 µs. This is long enough to enable time-gating techniques, which are necessary to overcome interferences from endogenous fluorescence during in vitro imaging studies [8] .
condensation approach. This led to microparticles showing high loading and homogeneous distribution of the functionality over the complete porous network. Detailed synthetic procedures for all syntheses are described in the supplementary. (7), N1-Re1-N3 78.61 (7) . Furthermore, the photophysical properties of 3-Re were studied. The UV-Vis spectrum of 3-Re shows a maximum absorbance at 323 nm with an extinction coefficient of 13696 M −1 ·cm −1 in CHCl3 under ambient conditions. The emission spectrum shows two distinct emissions at 426 and 546 nm. These data are in good agreement with Stephenson et al [8] . Under an inert gas atmosphere (N2), two emission maxima at 383 and 566 nm can be observed. The lifetime of the excited state determined in Therefore, it can be assumed that this reaction yields 3-Re@SBA-15 particles, which do not contain uncoordinated 3. This was confirmed by the addition of [ 99m Tc(H 2 O) 3 (CO) 3 ] + to these particles, which did not lead to a labeling of the particles. However, in the context of potential nuclearmedical applications, synthetic route a) would require a two-step procedure, starting with the synthesis of 3-186/188 Re, followed by the grafting process. The increased complexity of this synthetic procedure reduces its potential for clinic applications. From a theranostic point of view, the second approach (synthetic route b)) has higher relevance due to a one-step labeling procedure. Aiming to establish a feasible labeling for medical applications with the radio isotopes 186/188 Re and 99m Tc, [Re(H 2 O) 3 (CO) 3 ] + was chosen as a precursor for these reactions. In contrast to [Re(Br) 3 The labeling of 3@SBA-15 with [ 99m Tc(H 2 O) 3 (CO) 3 ] + (Scheme 5, synthetic route b)) to yield 3-99m Tc@SBA-15 was fast, with a labeling yield > 99%. Detailed information for this labeling procedure can be found in the Supplementary Materials (Supplementary Figure S4.3.4) . As for the screening of different silica materials, the labeling progress was indirectly analyzed by determining the decrease of activity in the solution. Prior to the reaction, radio-HPLC of the solution shows a clear signal for the [ 99m Tc(H 2 O) 3 (CO) 3 ] + complex at 5.5 min ( Figure 6 ). After 15 min at 100 • C (microwave), coordination of the { 99m Tc(CO) 3 } + onto the silica particles was confirmed by radio-HPLC. In addition, gamma counting of the filtered reaction solution showed a decrease of activity in the solution to almost background level. Since 3 is randomly distributed over the surface of these model particles, the labeling with 99m Tc is not preferential in the pores. a direct translation of the model reaction with [Re(H2O)3(CO)3] + into a labeling procedure with [ 186/188 Re(H2O)3(CO)3] + and [ 99m Tc(H2O)3(CO)3] + . Labeling of 3@SBA-15 particles, which contained 0.08 mmol 3/g particles (determined by EA) with an excess of [Re(H2O)3(CO)3] + , yielded 3-Re@SBA-15 particles with an Re loading of 0.077 mmol/g particles (determined by ICP-MS). The incomplete occupation of the bisquinoline ligands at the surface of these fluorescent 3-Re@SBA-15 particles allows for subsequent labeling with [ 99m Tc(H2O)3(CO)3] + in a second step (detail see Supplementary  Figure 4 The labeling of 3@SBA-15 with [ 99m Tc(H2O)3(CO)3] + (Scheme 5, synthetic route b)) to yield 3-99m Tc@SBA-15 was fast, with a labeling yield > 99%. Detailed information for this labeling procedure can be found in the Supplementary Materials (Supplementary Figure 4.3.4) . As for the screening of different silica materials, the labeling progress was indirectly analyzed by determining the decrease of activity in the solution. Prior to the reaction, radio-HPLC of the solution shows a clear signal for the [ 99m Tc(H2O)3(CO)3] + complex at 5.5 min ( Figure 6 ). After 15 min at 100 °C (microwave), coordination of the { 99m Tc(CO)3} + onto the silica particles was confirmed by radio-HPLC. In addition, gamma counting of the filtered reaction solution showed a decrease of activity in the solution to almost background level. Since 3 is randomly distributed over the surface of these model particles, the labeling with 99m Tc is not preferential in the pores. 
Synthesis and Labeling of a Bifunctional SBA-15 Construct with Re and 99m Tc
For the synthesis of a novel (nano)platform for theranostic applications, a bifunctionalized SBA-15 microparticle model construct was realized. In the synthesized model, a fluorescent dye, grafted preferentially to the external surface of the SBA-15 particles, mimics the targeting function. This was achieved with short reaction time, an apolar solvent (hexane), and a directing silane, such as 3-aminopropyltrimethoxyethoxyethoxysilane (APTMEES) [26] . Accordingly, the average pore size of the SBA-15 particles remained invariant upon the grafting of APTMEES (see Supplementary Materials) in contrast to the grafting of 3 to unmodified SBA-15 particles. Subsequently, the grafted amino groups of APTMEES were reacted with the red emitting dye eosin isothiocyanate (EOITC). In the third step, 3 was grafted to the SBA-15 particles at the still accessible surface. Finally, the bifunctionalized EOITC/3@SBA-15 particles were labeled with the {M(CO) 3 } + (M = Re, 99m Tc) precursors (Scheme 6).
CO vibrations at 2026, 1901, and 1891 cm −1 show the coordination of the {Re(CO)3} + moiety to 3.
The labeling of 3@SBA-15 with [ 99m Tc(H2O)3(CO)3] + (Scheme 5, synthetic route b)) to yield 3-99m Tc@SBA-15 was fast, with a labeling yield > 99%. Detailed information for this labeling procedure can be found in the Supplementary Materials (Supplementary Figure 4.3.4) . As for the screening of different silica materials, the labeling progress was indirectly analyzed by determining the decrease of activity in the solution. Prior to the reaction, radio-HPLC of the solution shows a clear signal for the [ 99m Tc(H2O)3(CO)3] + complex at 5.5 min ( Figure 6 ). After 15 min at 100 °C (microwave), coordination of the { 99m Tc(CO)3} + onto the silica particles was confirmed by radio-HPLC. In addition, gamma counting of the filtered reaction solution showed a decrease of activity in the solution to almost background level. Since 3 is randomly distributed over the surface of these model particles, the labeling with 99m Tc is not preferential in the pores. 
For the synthesis of a novel (nano)platform for theranostic applications, a bifunctionalized SBA-15 microparticle model construct was realized. In the synthesized model, a fluorescent dye, grafted preferentially to the external surface of the SBA-15 particles, mimics the targeting function. This was achieved with short reaction time, an apolar solvent (hexane), and a directing silane, such as 3-aminopropyltrimethoxyethoxyethoxysilane (APTMEES) [26] . Accordingly, the average pore size of the SBA-15 particles remained invariant upon the grafting of APTMEES (see Supplementary  Materials) in contrast to the grafting of 3 to unmodified SBA-15 particles. Subsequently, the grafted amino groups of APTMEES were reacted with the red emitting dye eosin isothiocyanate (EOITC). In the third step, 3 was grafted to the SBA-15 particles at the still accessible surface. Finally, the bifunctionalized EOITC/3@SBA-15 particles were labeled with the {M(CO)3} + (M = Re, 99m Tc) precursors (Scheme 6).
By choosing different excitation wavelengths, the two moieties EOITC and 3-Re can be excited separately in the same particle. Optical slices in the center of the particles were selected and representative images are shown in Figure 7 . The red emission assessed the preferential attachment of EOITC on the external surface. The "loading" of the {Re(CO)3} + complex to the pore surface is By choosing different excitation wavelengths, the two moieties EOITC and 3-Re can be excited separately in the same particle. Optical slices in the center of the particles were selected and representative images are shown in Figure 7 . The red emission assessed the preferential attachment of EOITC on the external surface. The "loading" of the {Re(CO) 3 We show in this feasibility study synthetic pathways and procedures towards a SBA-15-based target-specific theranostic nanoplatform, utilizing the theranostic pair 99m Tc/Re. This platform enables the combination of optical (fluorescence) and radio imaging with radio-and chemotherapy. The translation into a theranostic nanoplatform can be realized as soon as procedures for the synthesis of well-defined, non-agglomerated SBA-15 nanoparticles have been established.
Materials and Methods
Caution: 99m Tc is a γ-emitter. All experiments have to be performed in laboratories approved for working with low-level radioactive materials.
All chemicals were of reagent-grade quality or higher and were obtained from commercial suppliers. Solvents were used as received or dried over molecular sieves. Na[ 99m TcO 4 ] in 0.9% saline was eluted from a 99 Mo/ 99m Tc Ultra-Technekow FM generator purchased from Mallinckrodt Medical B.V. (Petten, The Netherlands). [ 99m Tc(H 2 O) 3 (CO) 3 ] + was synthesized according to an adapted version of a published procedure [58] . The [ 99m TcO 4 ]eluate (1-2 mL, obtained from the 99 Mo/ 99m Tc generator) was added to a N 2 -flushed microwave vial containing Na 2 (BH 3 CO 2 ) (4 mg, 0.040 mmol), disodium tartrate dihydrate (7.0 mg, 0.030 mmol), and disodium tetraborate pentahydrate (7 mg, 0.024 mmol), and heated in a microwave reactor for 10 min at 110 • C. Finally, the pH of the solution was adjusted to pH 7 by the addition of 80-100 µL 1 M HCl. The [ 99m TcO 3 (tacn)] + was synthesized according a literature procedure [59] .
Silica particles used in this study were of the MCM-41 and SBA-15 types. Due to their irregular morphological properties, such as size and shape, they are not suited for optical analysis by CLSM.
For that purpose, large spherical particles of the SBA-15 type (sSBA-15) were chosen. Besides these well-known microparticles of MCM-41 and SBA-15, hexagonal arrays of silica nanochannels (ASNCs), MCM-41-nanoparticles, and MCM-41 particles with various pore sizes were used in the initial screening. The particles were synthesized following literature procedures (sSBA-15 [26] , ASNCSs [60] , all others [61] ). Characteristics of the applied silica particles are summarized in table S1 in the supplementary information.
High-resolution mass spectrometry (HR-ESI-MS) was performed on a Bruker maXis QTof high-resolution mass spectrometer (Bruker GmbH, Bremen, Germany). 1 H and 13 C-NMR spectra were recorded in deuterated solvents on a Bruker AV-400 or Bruker AV-500 MHz spectrometer at 300 K. 13 29.84 ppm). The abbreviations for the peak multiplicities are as follows: s (singlet), d (doublet), dd (doublet of doublets), t (triplet), q (quartet), m (multiplet), br (broad). 29 Si-NMR spectra were recorded on a Bruker AV-500 MHz. Gamma-counting of the 99m Tc solutions was performed on a COBRA 5002 (Packard Instrument, Meriden, USA). Half-life time corrections for the labeling of silica particles were neglected due to the sequential measurement of the samples, with less than 5 min between two samples. Labeling of silica particles: The initial activity of the 99m Tc-solutions was determined prior to the addition of the particle suspension. According to the dilution (factor 2), the activity for t = 0 min was calculated.
HPLC analyses were performed on a Merck Hitachi LaChrom L 7100 pump coupled to a Merck Hitachi LaChrom L7200 tunable UV detector (Hitachi, Tokyo, Japan) and a radiodetector. UV-Vis detection was performed at 250 nm. The detection of radioactive 99m Tc complexes was performed with a Berthold LB508 (Berthold Technologies, Bad Wildbad, Germany) radiodetector equipped with a bismuth germanium oxid (BGO) cell. Separations were achieved on a Macherey-Nagel C18 reversed-phase column (nucleosil 10 ml, 250/3 mm) using a gradient methanol (solvent A) and 0.1% trifluoroacetic acid (solvent B). Applied HPLC gradient: 0-3 min: 0% A, 100% B; 3-3.1 min: 0-25% A, 100-75% B; 3.1-9 min: 25% A, 75% B; 9-9.1 min: 25-34% A, 75-66% B; 9.1-18 min: 34-100% A, 66-0% B; 18-25 min: 100% A, 0% B; 25-25.1 min: 100-0% A, 0-100% B; 25.1-30 min: 0% A, 100% B. The flow rate was 0.5 mL·min −1 . Ultra performance liquid chromatography-electrospray ionization-mass spectrometry (UPLC-ESI-MS) was performed on a Waters Acquity UPLC System coupled to a Bruker high capacity ion trap mass spectrometer (HCTM), using an Acquity UPLC ethylene bridge hybrid (BEH) C18 1.7 µm (2.1 × 50 mm) column. UPLC solvents were formic acid (0.1% in millipore water) (solvent A) and acetonitrile HPLC grade (solvent B). Applied UPLC gradient: 0-0.5 min: 95% A, 5% B; 0.51-4.0 min: linear gradient from 95% A (5% B) to 0% A (100% B); 4-5 min: 100% B. The flow rate was 0.6 mL/min. Detection was performed at 250 nm and 480 nm (diode-array detector). For preparative HPLC, a Varian ProStar 320 system (Varian Inc, Palo Alto, USA) was used with a Dr. Maisch Reprosil C18 100-7 (40 × 250 mm) column. The solvents (HPLC grade) were 0.1% trifluoroacetic acid (solvent A) and acetonitrile (solvent B). Applied HPLC gradient: 0-2 min: 66% A (34% B); 2-45 min: linear gradient from 66% A (34% B) to 0% A (100% B); 45-51 min: 100% B. The flow rate was 40 mL/min. Detection was performed at 235 nm.
IR spectra were recorded on a Perkin-Elmer FT-IR Spectrum Two spectrometer (Perkin-Elmer Inc., Waltham, USA), using ATR technique and applied as neat samples.
Nitrogen sorption isotherms were collected at 77 K using a Quantachrome NOVA 3000 (Quantachrome Instruments, Boynton Beach, USA). Samples were vacuum-degassed at 80 • C for 3 h. The total specific surface area was calculated by the Brunauer-Emmett-Teller (BET) method [62] . Mesopore size distributions were evaluated by the nonlocal density functional theory (NLDFT) method [63] developed for silica exhibiting cylindrical pore geometry (NOVAWin software, Version 11.0, Quantachrome Instruments, Boynton Beach, USA). The adsorption branch of the respective isotherm was used for the calculations.
The fluorescence and CLSM setup consisted of an Olympus BX60 microscope equipped with a FluoView FV300 confocal unit and lasers operating at 488 and 543.5 nm.
UV-Vis spectra were measured on a Cary 50 UV-Vis spectrometer or a SPECORD ® 250 PLUS spectrometer (Analytik Jena, Jena, Germany) with solution samples in 1 cm quartz cells.; λ max (ε) in nm; ε in M −1 ·cm −1 . Fluorescence spectra were recorded with a LS 50 B Luminescence spectrometer (Perkin-Elmer Inc., Waltham, USA); λ em (λ ex ) in nm. Lifetime and transient absorption measurements were recorded on a LP920-K laser flash photolysis transient absorption spectrometer using a flash-lamp-pumped, Q-switched Nd:YAG laser (355 nm) as the excitation source. Probing of the sample was conducted by a Xe920 probe lamp (450 W) and an xP920 pulsing unit module. Argon-purged solution samples in 1 cm quartz cells were used.
Microwave reactions were performed with a Biotage Initiator+ Robot Eight (Biotage, Uppsala, Sweden) or Anton Paar Monowave 200 instrument (Anton Paar GmbH, Graz, Austria).
Automated C18 column flash chromatography was run on a Flash Master Solo with an Argonaut UV-Vis detector from Omnilab and a Gilson FC 204 fraction collector. Separations were achieved by using C18 silica gel from Supelco packed into an ISOLUTE reservoir (70 mL) from Biotage. Flash column solvents were bidistilled water (solvent A) and MeOH (solvent B). Applied flash column gradient: 0-10 min: 90% A, 10% B; 10-70 min: linear gradient from 90% A, 10% B to 0% A, 100% B; 70-90 min: 0% A, 100% B. The flow rate was 2.0 mL·min −1 . Detection was performed at 220 to 240 nm. ICP-MS measurements were performed on an Agilent QQQ 8800 Triple quad spectrometer (Agilent Technologies, Santa Carla, USA), equipped with standard x-lens settings, nickel cones, and a "micro-mist" quartz nebulizer. All solutions were prepared from 60% HNO 3 (Merck 1.1518.500 ultrapure) and 18.2 MΩ Millipore water (Merck KGaA, Darmstadt, Germany). Re (Merck 1.70344.0100 H 2 O) was measured against a series of dilutions of single element standards (0-250 ng/mL).
Crystallographic data were collected at 183(2) K on a Rigaku OD XtaLAB Synergy Dualflex diffractometer (Rigaku Europe SE, Neu-Isenburg, Germany) equipped with a Pilatus 200 K detector and a PhotonJet Cu Kα source (λ = 1.54184 Å) or Mo Kα source (λ = 0.71073 Å). Suitable crystals were covered with oil (Infineum V8512, formerly known as Paratone N), placed on a nylon loop that was mounted in CrystalCap Magnetic™ (Hampton Research), and immediately transferred to the diffractometer. The program suite CrysAlis Pro was used for data collection, multi-scan absorption correction, and data reduction [64] . The structures were solved with direct methods using SHELXS-97 [65] and were refined by full-matrix least squares methods on F 2 with SHELXL-2014 [66] . The GUI ShelXle was employed [67] .
For NMR, ICP-MS, and (HR)-ESI-MS measurements of functionalized silica particles, a precise amount of these particles (typically 5-10 mg) were decomposed at room temperature for 1-20 h in 1 M NaOD in D 2 O (typically 0.7 mL) for NMR or 1M NaOH (typically 0.7 mL) for MS.
Detailed synthetic procedures for all reported reactions as well as control reactions are described in the supplementary information.
Synthesis of 1d
The 2-quinolinecarboxaldehyde (825 mg, 5.25 mmol) was dissolved in 1,2-dichloroethane (28 mL) and 4-aminobutyric acid (258 mg, 2.50 mmol) was added and stirred for 2 h at room temperature. Sodium triacetoxyborohydride (1.219 g, 5.75 mmol) was added and the solution was stirred at r.t. for 3 h. The 1,2-dichloroethane was evaporated in vacuo, the crude product was redissolved in dichloromethane ( 
Synthesis of 2
The 1d (28 mg, 0.07 mmol), 3-aminopropyltriethoxysilane (17.7 mg, 18.7 µL, 0.08 mmol) and hexafluorophosphate benzotriazole tetramethyl uronium (82.6 mg, 0.22 mmol) were dissolved in dry DMF (3 mL) and N,N-diisopropylethylamine (28 mg, 37.24 µL, 0.22 mmol) was added. The mixture was stirred at r.t. for 2 h. The organic phase was washed with H 2 O (3 × 10 mL), filtered, and the DMF was evaporated under reduced pressure to yield 2 ( 13 
Synthesis of 3
The 2-quinolinecarboxaldehyde (128 mg, 0.81 mmol) was dissolved in 1,2-dichloroethane (20 mL) and 3-aminopropyltriethoxysilane (87 mg, 92 µL, 0.40 mmol) was added. The mixture was stirred at 25 • C for 2 h, sodium triacetoxyborohydride (252 mg, 1.18 mmol) was added, and the mixture was stirred for 3.5 h at 25 • C. The 1,2-dichloroethane was evaporated in vacuo, EtOH (15 mL) was added, and stirred for 10 min at 25 • C. The EtOH was evaporated in vacuo. The residue was washed with toluene (20 mL) and the yellow solution was separated from the white precipitate by centrifugation. The toluene was evaporated to yield crude 3. 
Synthesis of Bifunctionalized Mesoporous Silica Particles (EOITC/3@SiP)
Silica particles (SiP = SBA-15, spherical sSBA-15) were dried by heating (140 • C) under high vacuum for 4 h, then dispersed in hexane, and 3-aminopropyltris(methoxyethoxyethoxy)silane (APTMEES) was added. The suspension was sonicated for 10 min at room temperature. The particles were recovered by filtration, washed with hexane (3 × 3 mL), and dried under high vacuum, yielding APTMEES@SiP. Eosin isothiocyanate (EOITC) was dissolved in EtOH (10 mL). APTMEES@SiP particles were added and the suspension was stirred at r.t. for 16 h. The particles were collected by filtration, washed with EtOH (50 mL) and H 2 O (50 mL), yielding EOITC/@SiP. Then, 3 was dissolved in dry toluene and added to dry EOITC/@SiP particles. The suspension was sonicated at 40 • C for 2 h. Finally, EOITC/3@SiP was filtered off, washed with toluene (5 mL) and Et 2 O (5 mL), and dried under high vacuum. . This solution was added to the EOITC/3@SiP (SiP = SBA-15, spherical sSBA-15) and the suspension was heated at 100 • C for 45 min by means of a microwave reactor. The formed EOITC/3-Re@SiP particles were collected by filtration, washed with H 2 O (2 mL) and toluene (4 mL), and dried under vacuum.
Labeling of Bifunctionalized Mesoporous Silica Particles (SiP) with [ 99m Tc(H 2 O) 3 (CO) 3 ] +
A microwave vial was charged with EOITC/3@SiP (SiP = SBA-15, sSBA-15) (10 mg) and saline (2 mL). The vial was flushed with N 2 (5 min). The [ 99m Tc(H 2 O) 3 (CO) 3 ] + (5-15 MBq) in saline (2 mL, pH 7) was added and the suspension was heated at 100 • C for 15 min in the microwave reactor. For reaction control, an aliquot (0.5 mL) was filtered and centrifuged, and the clear solution was used for radio-HPLC measurements. As an additional control, 10 µL of each centrifuged sample was collected and the remaining activity in solution was determined by means of a γ-counter.
Conclusions
We combined the multimodal properties of the bisquinoline/{M(CO) 3 } + system (M = 99m Tc, Re) with the theranostic properties of the 99m Tc/ 186/188 Re pair at a mesoporous silica support. The presented synthetic procedures are based on fundamental studies, which disclosed the most suitable mesoporous silica construct (SBA-15) for this development. Furthermore, a variety of different pathways was developed to synthesize bisquinoline-containing silanes, suitable for grafting reactions with silica particles. The hydrolysis of the trialkoxysilane moiety and subsequent cross-linking of the products had to be addressed. The successful functionalization of the external and the pore surface of the mesoporous silica particles was visualized by confocal laser scanning microscopy. The synthesized model system mimics a SBA-15-based target-specific theranostic nanoplatform, which enables the combination of fluorescence and radio imaging with the possibility of radio-and chemotherapy. Currently, we are using the reported procedures to synthesize target-specific nanoparticles for the first in vitro and in vivo studies.
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